UiPath Inc (PATH) Stock Analysis

Verdict: WATCH (do not buy)

UiPath's strong cash flow and $1.21B net cash provide a valuation floor, but growth decelerating to single digits limits near-term upside.

Investment score: 53/100

Analysis as of

Is UiPath Inc stock worth reviewing? AI model thesis

UiPath offers solid cash generation ($352M FY26 FCF) and a strong balance sheet ($1.21B net cash), but decelerating top-line growth to ~8-11% and zero insider buying keep the model on the sidelines.

7-factor investment score

UiPath Inc opportunities and risks

What speaks for PATH

What speaks against PATH

Peers and competitors

Trailing-twelve-month ratios
TickerP/EP/SEV/EBITDAGross marginNet marginFCF yield
PATH19.9x4.0x27.0x82.5%21.0%5.2%
GEN14.0x2.9x9.6x78.0%20.7%10.6%
FROGn/a18.5xn/a77.9%-7.3%1.5%
GTLBn/a8.5xn/a85.8%-5.0%2.4%
NTSKn/a10.0xn/a69.9%-91.8%-0.9%
Sn/a7.1xn/a73.3%-31.0%0.5%
Peer mediann/a8.5xn/a77.9%-7.3%1.5%

Frequently asked questions about UiPath Inc (PATH)

Is PATH stock a good investment?

The cached TradeMates AI model rates UiPath Inc as WATCH (do not buy) with an investment score of 53/100. UiPath offers solid cash generation ($352M FY26 FCF) and a strong balance sheet ($1.21B net cash), but decelerating top-line growth to ~8-11% and zero insider buying keep the model on the sidelines. This is algorithmic model output, not personal investment advice.

Is PATH stock a buy?

The TradeMates model verdict for PATH is WATCH (do not buy) with an investment score of 53/100. Treat this as a model signal to review, not a personal buy recommendation.